APPLICATION
ANDA091612
TYPE
ANDA
ORIGINAL APPROVAL
2015-03-18
LATEST ACTION
2017-10-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
TENOFOVIR DISOPROXIL FUMARATEPrescription
TENOFOVIR DISOPROXIL FUMARATE 200MG · TABLET · ORAL
TENOFOVIR DISOPROXIL FUMARATEPrescription
TENOFOVIR DISOPROXIL FUMARATE 300MG · TABLET · ORAL
TENOFOVIR DISOPROXIL FUMARATEPrescription
TENOFOVIR DISOPROXIL FUMARATE 250MG · TABLET · ORAL
TENOFOVIR DISOPROXIL FUMARATEPrescription
TENOFOVIR DISOPROXIL FUMARATE 150MG · TABLET · ORAL
Approval history
2018-01-26UNKNOWN · Supplement 1 · unknownTA
2017-10-24Labeling · Supplement 2 · standardAP
2017-10-24Labeling · Supplement 3 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.